{"name":"Stemedica Cell Technologies, Inc.","slug":"stemedica-cell-technologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Allogeneic Mesenchymal Bone Marrow Cells","genericName":"Allogeneic Mesenchymal Bone Marrow Cells","slug":"allogeneic-mesenchymal-bone-marrow-cells","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Allogeneic Mesenchymal Bone Marrow Cells","genericName":"Allogeneic Mesenchymal Bone Marrow Cells","slug":"allogeneic-mesenchymal-bone-marrow-cells","phase":"phase_1","mechanism":"Mesenchymal stem cells modulate immune responses and secrete factors that may promote tissue regeneration and reduce inflammation.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPaW5zaUVzZk9EZFNGMVJVZnJvNkdpT3ZDc2xDbllBT2NWbHY2MHFJdWFZcWg5dEpHR2M3MXYzV2FITlQtRF8wRHpsT0VBckhTMndkNmhvaEZWS2s2aFAtLTRFNEV4T0xHWVJWQ1k5aE5aNVk2TnUxeE5sd3owcFJBOEJwbUFKajA5Vzc4?oc=5","date":"2026-01-21","type":"pipeline","source":"pharmaphorum","summary":"Hopstem maps course to bring stem cell stroke therapy to US - pharmaphorum","headline":"Hopstem maps course to bring stem cell stroke therapy to US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPaUpjZWVBaHRGWXRIZ3Zibk1KT0pHaTNlUFd2aVhvaHZmSGFBcVBPeDVIdGQ1M2oyRVNWQ21wSVNqOXZseVNTX1lwU0lZcE9tbFVKVHlvVTUybzFiOFdHc1lialNhYXVmTHNzTHFRZGxRS1N3M2UzdUNDeXZvR3ZwTGJkdk1iaXJSWkVzT3NVZkUzWmJBM00tZEtuclVNMk52NUJqN1RGbjhCMjh1VmRRUmMtVElCZGtFZVI0UHd2bW81NmZjR3ZXZkZJY0JhWUtQZ0ZsbnpIbW11Q3BtQkhJeVhlQ1gwNFFlT2pzTFdZbVhJV3hkQTFVUktYQWdmSUJTSzdvbUFYT1Y1aW5UUHdEUW1jNy0wRU9Zb1R2MzJYNHZaeDhQODlYQkRDUG9kcExoa0dzWUxESktqY0hEMkZFQTVHQzJ2aGdKdURJUzNhMzA?oc=5","date":"2025-10-09","type":"regulatory","source":"Business Wire","summary":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040 - ResearchAndMarkets.com - Business Wire","headline":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldw","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOOEVpcy1BTVpvNDEtTW9vNHBCSmZOYXZTOUlJaWE4ck5oTlRlTnBLZDRVNko4WmU1SGVBUW9ZRWxOdWxwRmpBWThIVE1kNm1XLWZnbTlZYkpOMnFMZXR4a2h0WTJVcTJHVmJWVDhEMDZQOGpDRFZOY0lvY1VLb2JRanZ4U1d5MFVqRGs3SkREczRIa01XYnlXNF8tbWVXT3dKTXRJTkhmRmpQNS11SUliV0Nfak5WNzlHbmZGbkVycURrZ0RQb2QzVmljRkxJV2RKN0xrQ1ZkVW1HVlo5Yi1US0xWeGJBLUVTRGlVeUxfem9wbVNRN01jNjNpUVB2VXhF?oc=5","date":"2025-08-07","type":"pipeline","source":"BioSpace","summary":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent Market Insights - BioSpace","headline":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxORndHY3daWUhJWEJGMnZieF93aEs4TW12UXkzV0QxVU1BR2NjZGtmVkhOV0lIZWw2a3o5Z1VMTW9DTnBJZUFIblRGMnJrUThVZk9Sa1Y1UnlIazhCTmx4RlpFTm1GLWNJXzNubGhWbldzQzFYcGN0MmhpZkItMXljYXNoV0RfZEJZeEx1MmxIcmZDd3VibllsOF9CZ0xYLV9ZR0d5U3F3TFRHMURrZmdZTWVzX0Jldkhyam5BVnR2V2h5eUxLbUJOTGxMQUpnb0s0TDBpVEV5Ni12eFQzc3o0R2hyVQ?oc=5","date":"2024-06-06","type":"pipeline","source":"PR Newswire","summary":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight - PR Newswire","headline":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSWdSOHBwaGwtdE80eUJ4cVJteEg0VHE4M3hCdzNxcG5rQ05ZRU9LeUJGMEw4WU9tMnp0VXFib3lpUmJLenNJTl9kY2h6ZkNLdlVHSUx4WkhLa1BOSEwxcU5qR1FndXhPeFlHVDVLZUVlZWdENUJPWmhJMzhRR1RVcVVEWjhJV1pUZ0VGa29ZUDd6NnJEUU1jcDdYaVdzZ0txWkJjVUxiNUkzZllsek9oTk00dGVSakVKemFDa0xodGh5aDlXQ2xma0l5UUZ4azM1dnlfSDFPVnV2ZnBaQmc?oc=5","date":"2024-06-04","type":"pipeline","source":"PR Newswire","summary":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight - PR Newswire","headline":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOclFFNEo2bG8xTmpUVjdwckF3OFBTT0VVZjBCVHVoY0xEblNGc1NlWk9vNmtVck51T2NSdzNYUGVRVlRHdm5qUUstSnJnZzlIZkJDMmFneFQwaDJkZjlKeEpMaE5hTGZfdUp0S1JuX3Ztc3dEX3NQNWFBOTRmQzZUbzQ5ZmZjUWNodWE5TUN1QjRYZlgxVWY2VE84SDdlNVM3OTk0eVRoOWt6WVh3OUlmQzdSNnFQRXVZRVo3a2xSVi16a1BHMC1BUFowZjU4d2JBUUR4V1VpRWRmZkRmVEdMenZoTFNYNGd0MjNMSWV5X1hmSkJ4MTJrZFVxaTJQYmNRSTJFdFpRd1FSNnFMUG93?oc=5","date":"2023-06-14","type":"pipeline","source":"globenewswire.com","summary":"Global Cell Therapy Market Report 2023: Sector is Expected to Reach $62.39 Billion by 2030 at a CAGR of 14.2% - globenewswire.com","headline":"Global Cell Therapy Market Report 2023: Sector is Expected to Reach $62.39 Billion by 2030 at a CAGR of 14.2%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNcXdCbkstZGxTQmVxeGhMcEhQZDJCWGpscjIxOVpodERHcWJxSGdVT0Nabm1zTGVwejhWZU5Cb1lKX25FZjRPNUtxRHNQMTVXTEZ0S284VThPbEtpTjBHcVhvai03U19lZlF1dEtOSTVxSmZWN3V4dkw0NFZZTnVraXlqcG5LcmFpZWJ2UXEyTXdSd2ZvMXBBZUtNUVYtS2llV3FUQU9RdTVRWlRZZXpxMWhsajB3RmtDbWNmdXdRVU9RS3VKUC16OVVfY3ctWklrdFVXVE1FUV81Vl8yMVNfSTFJanNySWJFMDRRMjJTX3paOFBRQncyTg?oc=5","date":"2022-03-04","type":"pipeline","source":"Business Wire","summary":"GI Innovation Recruits Chief Executive Officer Byung-Geon Rhee Former CEO of GC Pharma, SCM Lifescience Corp. - Business Wire","headline":"GI Innovation Recruits Chief Executive Officer Byung-Geon Rhee Former CEO of GC Pharma, SCM Lifescience Corp.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFA2NzBXREFaV0NGNDBla2F0Nm56YlJMRFprS3k3cGdWTmd5ZVNkMF9pSmxoTkJHMnpORE16MkkyZ19POFZpM09jNG5ZcHVrQkxseWgxUXlyTWVsSjk5cVNVMXk0Nmo4UQ?oc=5","date":"2018-12-28","type":"pipeline","source":"Market.us","summary":"Mesenchymal Stem Cells Market Size, Share | CAGR Of 12.6% - Market.us","headline":"Mesenchymal Stem Cells Market Size, Share | CAGR Of 12.6%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPNHhzcmxjcW5EaTZpTFpEN0RKb1JVOGhzTThiVDJMQVRNQVhvclRSVHdPQ3hqS1YzV0hrNS1rUnJhcjc2ZFpQeFlOa0pITzZYaG1PSEpYSXNSeUVSU1J3Mk1KWXZiZEV4cEVBekYyVXRaRFFtZ09EM25NNXQ4eDdTeU4wTmhidU9hS1pQQk5xTkVpV0QwckhSMG54RXBRdXM?oc=5","date":"2016-08-17","type":"pipeline","source":"Contract Pharma","summary":"Cryoport Expands Cold Chain Agreement with Stemedica - Contract Pharma","headline":"Cryoport Expands Cold Chain Agreement with Stemedica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNOTI2T2VKdzUyTDIyQjc1YzdmMExjSXgwTnZtWkVXb3Znal9qci1MWHRrVkFHdXNvZm9xOUk5S0dtcHowWkRJM05jU0hwOFMwRFFHdjU0TW5MZFdDYUcxbUVfcDZuc1MtQ281bGl0V0QxZFlZSkRDelpqOC1HUWhCbDZEUzgzWmNKd0hRNw?oc=5","date":"2015-08-17","type":"trial","source":"Clinical Leader","summary":"The Ethical Dilemma Of Patient-Funded Trials - Clinical Leader","headline":"The Ethical Dilemma Of Patient-Funded Trials","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}